Jerome D Jabbour - Net Worth and Insider Trading
Jerome D Jabbour Net Worth
The estimated net worth of Jerome D Jabbour is at least $82,430 dollars as of 2024-08-24. Jerome D Jabbour is the President and CEO of Matinas BioPharma Holdings Inc and owns about 799,511 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $82,430. Details can be seen in Jerome D Jabbour's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jerome D Jabbour has not made any transactions after 2020-03-17 and currently still holds the listed stock(s).
Transaction Summary of Jerome D Jabbour
Jerome D Jabbour Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jerome D Jabbour owns 1 companies in total, including Matinas BioPharma Holdings Inc (MTNB) .
Click here to see the complete history of Jerome D Jabbour’s form 4 insider trades.
Insider Ownership Summary of Jerome D Jabbour
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2020-03-17 | director & Chief Executive Officer |
Jerome D Jabbour Latest Holdings Summary
Jerome D Jabbour currently owns a total of 1 stock. Jerome D Jabbour owns 799,511 shares of Matinas BioPharma Holdings Inc (MTNB) as of March 17, 2020, with a value of $82,430.
Latest Holdings of Jerome D Jabbour
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2020-03-17 | 799,511 | 0.10 | 82,430 |
Holding Weightings of Jerome D Jabbour
Jerome D Jabbour Form 4 Trading Tracker
According to the SEC Form 4 filings, Jerome D Jabbour has made a total of 1 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 10,000 shares on March 17, 2020, which cost Jerome D Jabbour around $6,500.
Insider Trading History of Jerome D Jabbour
- 1
Jerome D Jabbour Trading Performance
GuruFocus tracks the stock performance after each of Jerome D Jabbour's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jerome D Jabbour is 30.49%. GuruFocus also compares Jerome D Jabbour's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jerome D Jabbour within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jerome D Jabbour's insider trading performs compared to the benchmark.
Performance of Jerome D Jabbour
Jerome D Jabbour Ownership Network
Ownership Network List of Jerome D Jabbour
Ownership Network Relation of Jerome D Jabbour
Jerome D Jabbour Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
Jerome D Jabbour is the director & Chief Executive Officer of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , Chief Financial Officer Keith A Kucinski , and Chief Medical Officer Ferguson James J. Iii .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
Jerome D Jabbour Mailing Address
Above is the net worth, insider trading, and ownership report for Jerome D Jabbour. You might contact Jerome D Jabbour via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206, Suite 302, Bedminster Nj 07921.